Uncommon response of cisplatin and etoposide for treatment of advanced medullary thyroid carcinoma

Systemic treatment of Medullary thyroid carcinoma (MTC) is currently limited to the use of a tyrosine kinase inhibitor. Cytotoxic chemotherapy is not routinely recommended in the earlier lines of treatment due to the lack of efficacy. We describe a patient with locally advanced MTC who had an uncomm...

Descripción completa

Detalles Bibliográficos
Autores principales: Panomuppakarn, Nathamon, Witoonpanich, Patamintita, Waisayarat, Jariya, Jiarpinitnun, Chuleeporn, Ativitavas, Touch, Ngamphaiboon, Nuttapong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628208/
https://www.ncbi.nlm.nih.gov/pubmed/29026560
http://dx.doi.org/10.1002/ccr3.1123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628208/
https://www.ncbi.nlm.nih.gov/pubmed/29026560
http://dx.doi.org/10.1002/ccr3.1123

Ejemplares similares